Description: Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, food, animal healthcare, biotech, crop protection, and specialty chemicals and biocides companies. It operates in two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was founded in 1988 and is headquartered in Navi Mumbai, India.
Home Page: www.hikal.com
Great Eastern Chambers
Navi Mumbai,
400614
India
Phone:
91 22 3097 3100
Officers
| Name | Title |
|---|---|
| Mr. Sameer Hiremath | Joint MD, CEO & Whole Time Director |
| Mr. Sham V. Wahalekar | CFO & Pres of Fin. |
| Dr. Sudhir Nambiar | Pres of Research & Technology |
| Mr. Rajasekhar Reddy | Whole-Time Company Sec. & Compliance Officer |
| Mr. Kumaar Priyaranjan | Pres of Human Capital & CSR |
| Mr. Anish Dilip Swadi | Pres of Strategy & Bus. Devel. |
| Mr. Manoj Mehrotra | Pres of Pharmaceuticals Bus. |
| Dr. T. Devanathan | Head of IP & Quality, Pharmaceuticals |
| Mr. Kumar Inamdar | Pres of Crop Protection Bus. |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 22.5878 |
| Price-to-Book MRQ: | 2.5019 |
| Price-to-Sales TTM: | 1.4221 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1629 |